Latest News

Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects.

Source link

Related posts

Portfolio diet lowers many risk factors for heart disease

Newsemia

U.S. Hospital Beds Were Maxed Out Before Pandemic

Newsemia

U.S. Suicide Rate Rose 33% Between 1999 and 2017

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World